Tajikistan vs Togo: The number of people with susceptibility test result for rifampicin
Tajikistan
1,862
in 2021
Togo
1,805
in 2021
Tajikistan rank
50th
Togo rank
52nd
The number of people with susceptibility test result for rifampicin over time
- Tajikistan
- Togo
How they compare
Tajikistan currently reports 1,862 against 1,805 in Togo, a difference of 57.
Across all 5 years both countries report, Tajikistan has been ahead every year.
Tajikistan ranks 50th and Togo ranks 52nd of 155 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Tajikistan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,412 | 732 | 1,680 | Tajikistan |
| 2020s | 1,772 | 1,709 | 63.5 | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Tajikistan or Togo?
- Tajikistan, at 1,862 against 1,805 in Togo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Tajikistan and Togo?
- 57, with Tajikistan ahead.
- How many years of comparable data are there for Tajikistan and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Tajikistan and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Tajikistan ranks 50th and Togo ranks 52nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.